Unlocking the Power of Novel HER3-Targeting Agents in NSCLC and Breast Cancer: Expert Insights and Considerations for Precision Care

Read a Call to Action commentary, view CME-certified microlearning text modules, download slidesets, and listen to a podcast conversation on HER3, a novel therapeutic target under investigation in multiple solid tumor types, from an expert panel including specialists in breast and lung cancers.

Share

Program Content

Activities

HER3 ADC commentary
HER3-Targeted Antibody–Drug Conjugates for Lung and Breast Cancers: Where We Are Today
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 29, 2023

View Activity

Activities

HER3 Breast Text Module
Elevating the Science of HER3-Targeted Therapy to Improve Outcomes in Breast Cancer
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 13, 2023

Expires: October 12, 2024

View Activity
HER3 Rationale Text Module
Expanding Our Understanding of HER3 Expression, Implications, and Rationale for HER3-Targeted Therapy in Solid Tumors
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 20, 2023

Expires: October 19, 2024

View Activity
HER3 NSCLC Text Module
Exploring the Clinical Landscape of Novel HER3-Targeted Treatments for Advanced NSCLC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: November 06, 2023

Expires: November 05, 2024

View Activity

Activities

HER3 Breast Slideset
Elevating the Science of HER3-Targeted Therapy to Improve Outcomes in Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 13, 2023

View Activity
HER3 Rationale Slideset
Expanding Our Understanding of HER3 Expression, Implications, and Rationale for HER3-Targeted Therapy in Solid Tumors
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 20, 2023

View Activity
HER3 NSCLC Slideset
Exploring the Clinical Landscape of Novel HER3-Targeted Treatments for Advanced NSCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 06, 2023

View Activity

Activities

HER3 Podcast
Expert Insights and Considerations for Precision Care With HER3-Targeted Agents in NSCLC and Breast Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 07, 2023

View Activity

Faculty

cover img faculity

Aakash Desai, MD, MPH

Assistant Professor of Medicine 
O'Neal Comprehensive Cancer Center
University of Alabama at Birmingham
Birmingham, Alabama

cover img faculity

Narjust Florez, MD

Associate Director of The Cancer Care Equity Program
Thoracic Medical Oncologist, Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School
Associate Editor
JAMA Oncology
Boston, Massachusetts

cover img faculity

Rebecca S. Heist, MD, MPH

Associate Professor of Medicine
Harvard Medical School
Medical Oncology
Massachusetts General Hospital
Boston, Massachusetts

cover img faculity

Misako Nagasaka, MD, PhD

Associate Clinical Professor
Division of Hematology/Oncology
Department of Medicine
University of California Irvine School of Medicine
Orange, California

cover img faculity

Paolo Tarantino, MD

Advanced Research Fellow
Harvard Medical School
Department of Breast Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Helena Yu, MD

Associate Attending
Research Director of Thoracic Oncology Service
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Yuan Yuan, MD, PhD

Director, Breast Oncology
Cedars-Sinai Medical Center
Los Angeles, California

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.